Loading...
Is fibrinogen the answer to coagulopathy after massive transfusions?
Coagulopathy is a major cause of morbidity and mortality in patients who have suffered severe hemorrhage and received massive transfusions. Administration of a fibrinogen concentrate along with red blood cells can quickly restore hemostasis in a clinically relevant animal model.
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2911703/ https://ncbi.nlm.nih.gov/pubmed/20497599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc9000 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|